Latest: FDA Approves New Biosimilar for Oncology Treatment
Medical Research

STAT+: Pharmalittle: We’re reading about a Massachusetts biotech slump, Akeso lung cancer survival data, and more

by STAT News
0 Comments
0 Mins
A new report paints a grim outlook for the Massachusetts biotech industry, as venture investment fell 17% in the first half of 2025
Tags:
STAT News
Author

STAT News

Previous Post
Rimidi Partners with Beth Israel Deaconess Medical Center on Food as Medicine Trial
Next Post
EAST-AFNET 4 Trial: Early Rhythm Control vs Usual Care in Atrial Fibrillation (East AF) [Classics Series]
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago